Results for tag: "D4 Antagonist"

The D4 Antagonist market is a subset of the Central Nervous System Drugs market. It is composed of drugs that act as antagonists to the D4 receptor, a type of dopamine receptor found in the brain. These drugs are used to treat a variety of conditions, including schizophrenia, bipolar disorder, and attention deficit hyperactivity disorder (ADHD). They are also used to treat the side effects of antipsychotic medications. D4 Antagonists are typically administered orally, and are available in both generic and brand-name formulations. Common side effects of these drugs include drowsiness, dry mouth, and nausea. The D4 Antagonist market is highly competitive, with a number of major pharmaceutical companies vying for market share. Companies in the market include Eli Lilly, Pfizer, Novartis, and Johnson & Johnson. Show Less Read more